259 related articles for article (PubMed ID: 15271240)
1. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
Schramm J; Luyken C; Urbach H; Fimmers R; Blümcke I
Neurosurgery; 2004 Aug; 55(2):340-7; discussion 347-8. PubMed ID: 15271240
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.
Luyken C; Blümcke I; Fimmers R; Urbach H; Elger CE; Wiestler OD; Schramm J
Epilepsia; 2003 Jun; 44(6):822-30. PubMed ID: 12790896
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of supratentorial astrocytoma WHO grade II.
Peraud A; Ansari H; Bise K; Reulen HJ
Acta Neurochir (Wien); 1998; 140(12):1213-22. PubMed ID: 9932120
[TBL] [Abstract][Full Text] [Related]
4. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
[TBL] [Abstract][Full Text] [Related]
5. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
Slegers RJ; Blumcke I
Acta Neuropathol Commun; 2020 Mar; 8(1):27. PubMed ID: 32151273
[TBL] [Abstract][Full Text] [Related]
6. Low grade supratentorial astrocytomas. Management and prognostic factors.
Janny P; Cure H; Mohr M; Heldt N; Kwiatkowski F; Lemaire JJ; Plagne R; Rozan R
Cancer; 1994 Apr; 73(7):1937-45. PubMed ID: 8137221
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
9. Preoperative history and postoperative survival of supratentorial low-grade astrocytomas.
Afra D; Osztie E; Sipos L; Vitanovics D
Br J Neurosurg; 1999 Jun; 13(3):299-305. PubMed ID: 10562842
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
[TBL] [Abstract][Full Text] [Related]
11. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
12. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas.
Piepmeier J; Christopher S; Spencer D; Byrne T; Kim J; Knisel JP; Lacy J; Tsukerman L; Makuch R
Neurosurgery; 1996 May; 38(5):872-8; discussion 878-9. PubMed ID: 8727811
[TBL] [Abstract][Full Text] [Related]
13. Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.
Kreth FW; Faist M; Grau S; Ostertag CB
Cancer; 2006 Mar; 106(6):1372-81. PubMed ID: 16470609
[TBL] [Abstract][Full Text] [Related]
14. Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long-term results of 97 patients.
Hanzély Z; Polgár C; Fodor J; Brucher JM; Vitanovics D; Mangel LC; Afra D
J Neurooncol; 2003 Jul; 63(3):305-12. PubMed ID: 12892238
[TBL] [Abstract][Full Text] [Related]
15. Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas.
Bagley JH; Babu R; Friedman AH; Adamson C
Neurosurg Focus; 2013 Feb; 34(2):E7. PubMed ID: 23373452
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients.
Nicolato A; Gerosa MA; Fina P; Iuzzolino P; Giorgiutti F; Bricolo A
Surg Neurol; 1995 Sep; 44(3):208-21; discussion 221-3. PubMed ID: 8545771
[TBL] [Abstract][Full Text] [Related]
17. Grading of astrocytomas. A simple and reproducible method.
Daumas-Duport C; Scheithauer B; O'Fallon J; Kelly P
Cancer; 1988 Nov; 62(10):2152-65. PubMed ID: 3179928
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for supratentorial low grade astrocytomas in adults.
Iwabuchi S; Bishara S; Herbison P; Erasmus A; Samejima H
Neurol Med Chir (Tokyo); 1999 Apr; 39(4):273-9; discussion 279-81. PubMed ID: 10358980
[TBL] [Abstract][Full Text] [Related]
19. Malignant supratentorial astrocytomas of late childhood. Our experience with 25 cases.
Raco A; Bristot R; Salvati M; Delfini R
Childs Nerv Syst; 1997 Jun; 13(6):341-4. PubMed ID: 9272287
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and survival of spinal cord astrocytomas.
Zhang YW; Chai RC; Cao R; Jiang WJ; Liu WH; Xu YL; Yang J; Wang YZ; Jia WQ
Cancer Med; 2020 Oct; 9(19):6996-7006. PubMed ID: 32777166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
